Showing results (301-310 of 644) with videos related to

Sort By:
Pageof 65
Science (New York, N.Y.)|September 26, 2009
Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycleJae-Eun Kang, Miranda M Lim, Randall J Bateman, et al.
Molecular Neurodegeneration|April 19, 2015
Effects of CD2-associated protein deficiency on amyloid-β in neuroblastoma cells and in an APP transgenic mouse modelFan Liao, Hong Jiang, Subhashini Srivatsan, et al.
Acta Neuropathologica|September 9, 2018
Astrocytic degeneration in chronic traumatic encephalopathyEric T Hsu, Mihika Gangolli, Shiran Su, et al.
The Journal of Comparative Neurology|January 18, 2003
PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structuresRobert P Brendza, Cara O'Brien, Kelly Simmons, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 4, 2011
Dynamic analysis of amyloid β-protein in behaving mice reveals opposing changes in ISF versus parenchymal Aβ during age-related plaque formationSoyon Hong, Omar Quintero-Monzon, Beth L Ostaszewski, et al.
The American Journal of Pathology|March 19, 2013
Blocking the interaction between apolipoprotein E and Aβ reduces intraneuronal accumulation of Aβ and inhibits synaptic degenerationMagdalena A Kuszczyk, Sandrine Sanchez, Joanna Pankiewicz, et al.
Proteomics. Clinical Applications|December 8, 2010
Identification and validation of novel CSF biomarkers for early stages of Alzheimer's diseaseYan Hu, Ava Hosseini, John S K Kauwe, et al.
Neurobiology of Aging|June 19, 2016
NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkersStephanie J B Vos, Brian A Gordon, Yi Su, et al.
Archives of Neurology|December 17, 2009
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer diseaseJohn C Morris, Catherine M Roe, Elizabeth A Grant, et al.
Pageof 65